Publications

Distinguishing cell-cell complexes from dual lineage cells using single-cell transcriptomics is not trivial

Burel JG, Chawla A, Greenbaum JA, Peters B

A simple standard for sharing ontological mappings (SSSOM)

Matentzoglu N, Balhoff JP, Bello SM, Bizon C, Brush M, Callahan TJ, Chute CG, Duncan WD, Evelo CT, Gabriel D, Graybeal J, Gray A, Gyori BM, Haendel M, Harmse H, Harris NL, Harrow I, Hegde HB, Hoyt AL, Hoyt CT, Jiao D, Jiménez-Ruiz E, Jupp S, Kim H, Koehler S, Liener T, Long Q, Malone J, McLaughlin JA, McMurry JA, Moxon S, Munoz-Torres MC, Osumi-Sutherland D, Overton JA, Peters B, Putman T, Queralt-Rosinach N, Shefchek K, Solbrig H, Thessen A, Tudorache T, Vasilevsky N, Wagner AH, Mungall CJ

Bioinformatic analysis underpinning the frequent occurrence of immune thrombocytopenic purpura in COVID-19 patients

Frankel AE, Wylie D, Peters B, Marrama D, Ahn C

Disruption of mitochondrial quality control genes promotes caspase-resistant cell survival following apoptotic stimuli

Kushnareva Y, Moraes V, Suess J, Peters B, Newmeyer DD, Kuwana T

Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer

McCann K, von Witzleben A, Thomas J, Wang C, Wood O, Singh D, Boukas K, Bendjama K, Silvestre N, Nielsen FC, Thomas G, Sanchez-Elsner T, Greenbaum J, Schoenberger S, Peters B, Vijayanand P, Savelyeva N, Ottensmeier C

Towards the prediction of non-peptidic epitopes

Zierep PF, Vita R, Blazeska N, Moumbock AFA, Greenbaum JA, Peters B, Günther S

Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors

Sooda A, Rwandamuriye F, Wanjalla CN, Jing L, Koelle DM, Peters B, Leary S, Chopra A, Calderwood MA, Mallal SA, Pavlos R, Watson M, Phillips EJ, Redwood AJ

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigensn- adaptive T cell responses in humans

Marrama D, Mahita J, Sette A, Peters B

Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.

Burel JG, Singhania A, Dubelko P, Muller J, Tanner R, Parizotto E, Dedicoat M, Fletcher TE, Dunbar J, Cunningham AF, Lindestam Arlehamn CS, Catanzaro DG, Catanzaro A, Rodwell T, McShane H, O'Shea MK, Peters B.

OBO foundry in 2021: operationalizing open data principles to evaluate ontologies.

Jackson R, Matentzoglu N, Overton JA, Vita R, Balhoff JP, Buttigieg PL, Carbon S, Courtot M, Diehl AD, Dooley DM, Duncan WD, Harris NL, Haendel MA, Lewis SE, Natale DA, Osumi-Sutherland D, Ruttenberg A, Schriml LM, Smith B, Stoeckert CJ Jr, Vasilevsky NA, Walls RL, Zheng J, Mungall CJ, Peters B.